UBS O'Connor’s ARYA Sciences Acquisition Corp V Class A Ordinary Shares ARYE Stock Holding History

UBS O'Connor’s Portfolio ARYE Stock Details ARYE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-181,263	Closed	-$1.88M	–	700
2023 Q2	$1.88M	Sell	181,263 -4,086	-2%	-$42.1K	0.04%	307
2023 Q1	$1.9M	Hold	185,349	–	–	0.04%	329
2022 Q4	$1.86M	Sell	185,349 -1,814	-1%	-$18K	0.03%	479
2022 Q3	$1.84M	Sell	187,163 -18,737	-9%	-$183K	0.02%	647
2022 Q2	$2M	Hold	205,900	–	–	0.02%	653
2022 Q1	$2M	Buy	+205,900	New	+$1.99M	0.02%	600

UBS O'Connor's ARYE Position: Q3 2023 in Review

UBS O'Connor sold out of ARYA Sciences Acquisition Corp V Class A Ordinary Shares (ARYE) in Q3 2023, closing a stake of 181,263 shares — an estimated $1.88M sold.

UBS O'Connor first reported a position in ARYE in Q1 2022 and held it in 6 quarters. The position peaked at $2M in Q2 2022. 0 funds tracked by Wall St. Rank hold ARYE as of Q3 2023.

UBS O'Connor reported no remaining ARYA Sciences Acquisition Corp V Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
UBS O'Connor sold 181,263 ARYA Sciences Acquisition Corp V Class A Ordinary Shares shares in Q3 2023, an estimated $1.88M.
UBS O'Connor first reported a position in ARYA Sciences Acquisition Corp V Class A Ordinary Shares in Q1 2022 and held it in 6 quarters.
UBS O'Connor's ARYA Sciences Acquisition Corp V Class A Ordinary Shares position peaked at $2M in Q2 2022.
0 funds tracked by Wall St. Rank held ARYA Sciences Acquisition Corp V Class A Ordinary Shares as of Q3 2023.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.